Clinical trial
Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome: A Phase II Trial
NCT04447846 is registered in ClinicalTrials.gov with Anne Comi, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome: A Phase II Trial
- Lead sponsor
- Anne Comi, MD
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 14, 2019
- Completion date
- December 9, 2022
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.